Is omega-3 fatty acid deficiency a factor contributing to refractory seizures and SUDEP? A hypothesis

Seizure

Volumn 13, Issue 2, 2004, Pages 104-107

  Yuen, Alan W C ^a   Sander, Josemir W ^b  

^a EPILEPSY SOCIETY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Anti inflammatory mediators; Cardiac arrhythmias; Epilepsy; Omega 3 fatty acids; SUDEP

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOTROPIN; CYCLOOXYGENASE 2; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID; PHOSPHOLIPASE A2; PREDNISONE;

ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ANTICONVULSANT ACTIVITY; ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; EPILEPSY; ESSENTIAL FATTY ACID DEFICIENCY; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HYPOTHESIS; MALE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SEIZURE; SUDDEN DEATH; UNITED KINGDOM;

EID: 1242296881     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1059-1311(03)00108-0     Document Type: Article

References (23)

1. Hanna, N. J., Black, M., Sander, J. W. S. et al. The National Sentinel Clinical Audit of Epilepsy-Related Death: Epilepsy-Death in the Shadows. The Stationery Office, 2002.
2. Sander, J. W. Some aspects of prognosis in the epilepsies: a review. Epilepsia 1993; 34: 1007-1016.
3. Sanders, T. A. Polyunsaturated fatty acids in the food chain in Europe. American Journal of Clinical Nutrition 2000; 71: 176S-178S.
4. Zijlmans, M., Flanagan, D. and Gotman, J. Heart rate changes and ECG abnormalities during epileptic seizures: prevalence and definition of an objective clinical sign. Epilepsia 2002; 43: 847-854.
5. Nilsson, L., Farahmand, B. Y., Persson, P. G. et al. Risk factors for sudden unexpected death in epilepsy: a case-control study. Lancet 1999; 53: 888-893.
6. Lhatoo, S. D., Langan, Y. and Sander, J. W. Sudden unexpected death in epilepsy. Postgraduate Medical Journal 1999; 75: 706-709.
7. Schraeder, P. L. and Lathers, C. M. Paroxysmal autonomic dysfunction. Epilepsy Research 1989; 3: 55-62.
8. Xiao, Y. and Li, X. Polyunsaturated fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation. Brain Research 1999; 846: 112-121.
9. Voskuyl, R. A., Vreugdenhil, M., Kang, J. X. and Leaf, A. Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model. European Journal of Pharmacology 1998; 341: 145-152.
10. Yehuda, S., Carasso, R. L. and Mostofsky, D. I. Essential fatty acid preparation (SR-3) raises the seizure threshold in rats. European Journal of Pharmacology 1994; 254: 193-198.
11. Naffah-Mazzacoratti, M. G., Bellissimo, M. I. and Cavalheiro, E. A. Profile of prostaglandin levels in the rat hippocampus in pilocarpine model of epilepsy. Neurochemistry International 1995; 27: 461-466.
12. Vezzani, A., Moneta, D., Richichi, C. et al. Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis. Epilepsia 2002; 43 (Suppl. 5): 30-35.
13. Bazan, N. G., Tu, B. and Rodriguez de Turco, E. B. What synaptic lipid signaling tells us about seizure-induced damage and epileptogenesis. Progress in Brain Research 2002; 135: 175-185.
14. Okada, K., Yuhi, T., Tsuji, S. and Yamashita, U. Cyclooxygenase-2 expression in the hippocampus of genetically epilepsy susceptible E1 mice was increased after seizure. Brain Research 2001; 894: 332-335.
15. Finnen, M. J. and Lovell, C. R. Purification and characterisation of phospholipase A2 from human epidermis. Biochemical Society Transactions 1991; 19: 91S.
16. Obata, T., Nagakura, T., Masaki, T. et al. Eicosapentaenoic acid inhibits prostaglandin D2 generation by inhibiting cyclo-oxygenase-2 in cultured human mast cells. Clinical and Experimental Allergy 1999; 29: 1129-1135.
17. Schlanger, S., Shinitzky, M. and Yam, D. Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia 2002; 43: 103-104.
18. Kang, J. X. and Leaf, A. Prevention of fatal cardiac arrhythmias by polyunsaturated fatty acids. American Journal of Clinical Nutrition 2000; 71: 202S-207S.
19. Dietary supplementation with n-3 polyunsaturated fatty acids and Vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Lancet 1999; 354: 447-455.
20. Marchioli, R., Barzi, F., Bomba, E. et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002; 105: 1897-1903.
21. Albert, C. M., Hennekens, C. H., O'Donnell, C. J. et al. Fish consumption and risk of sudden cardiac death. The Journal of the American Medical Association 1998; 279: 23-28.
22. Horrobin, D. F., Jenkins, K., Bennett, C. N. and Christie, W. W. Eicosapentaenoic acid and arachidonic acid: collaboration and not antagonism is the key to biological understanding. Prostaglandins, Leukotrienes and Essential Fatty Acids 2002; 66: 83-90.
23. Annegers, J. F., Coan, S. P., Hauser, W. A. et al. Epilepsy, vagal nerve stimulation by the NCP system, mortality, and sudden, unexpected, unexplained death. Epilepsia 1998; 39: 206-212.